1-2 of 2
Biao Xing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

SD-101, a Novel Class C CpG-Oligodeoxynucleotide (ODN) Toll-like Receptor 9 (TLR9) Agonist, Given with Low Dose Radiation for Untreated Low Grade B-Cell Lymphoma: Interim Results of a Phase 1/2 Trial

Ronald Levy, MD, Patrick M. Reagan, MD, Jonathan W. Friedberg, MD, Nancy L Bartlett, MD, Leo I. Gordon, MD, Abraham Leung, MD, Joanna Peterkin, MD MS, Biao Xing, Robert Coffman, PhD, Robert Janssen, MD, Albert Candia, PhD, Michael Khodadoust, MD PhD, Matthew J. Frank, MD PhD, Steven R Long, MD, Debra K Czerwinski, Michael Chu, MD
Journal: Blood
Blood (2016) 128 (22): 2974.
https://doi.org/10.1182/blood.V128.22.2974.2974
Published: 2016
Journal Articles

Carfilzomib, Lenalidomide, and Dexamethasone vs Lenalidomide and Dexamethasone in Patients (Pts) with Relapsed Multiple Myeloma: Interim Results from ASPIRE, a Randomized, Open-Label, Multicenter Phase 3 Study

A. Keith Stewart, MD, S. Vincent Rajkumar, MD, Meletios A. Dimopoulos, Tamás Masszi, MD PhD, Ivan Spicka, Prof. MD PhD, Albert Oriol, MD, Roman Hájek, MD PhD Prof. of Oncology, Laura Rosiñol, MD PhD, David S. Siegel, MD PhD, Georgi G. Mihaylov, MD PhD, Veselina Goranova-Marinova, MD PhD, Péter Rajnics, MD PhD, Aleksandr Suvorov, MD, Ruben Niesvizky, MD, Andrzej Jakubowiak, MD PhD, Jesus F. San Miguel, Heinz Ludwig, Univ. Prof. Dr., Naseem Zojwalla, MD, Margaret E. Tonda, PharmD, Biao Xing, PhD, Philippe Moreau, Antonio Palumbo, MD
Journal: Blood
Blood (2014) 124 (21): 79.
https://doi.org/10.1182/blood.V124.21.79.79
Published: 2014